Am J Transplant, Volume 21, Suppl 3 Archives - Page 67 of 139 - ATC Abstracts

2021 American Transplant Congress
Infectious Complications and Malignancy After Kidney Transplantation in the Elderly Population
L. Liriano-Ward, M. Parides, Y. Al Azzi, C. Pynadath, M. Ajaimy, P. Loarte, J. Graham, S. Greenstein, M. Le, H. Yaffe, M. Kinkhabwala, J. Rocca, E. Akalin
Montefiore Medical Center, New York, NY
*Purpose: All patients, regardless of age, may benefit from renal transplantation due to improved quality of life and decreased mortality. However, elderly patients are at…
2021 American Transplant Congress
Belatacept Pharmacokinetics in Patients with and without Infection
A. Bickenbach¹, M. McGowan¹, B. Miyagawa², T. Mizuno², A. Shields³, A. Christianson¹, P. West-Thielke⁴, J. Leone⁵, E. Woodle¹, D. Kaufman⁶, A. Wiseman⁷, A. Vinks², R. Alloway¹
¹U Cincinnati, Cincinnati, OH, ²Cincinnati Children's Med Center, Cincinnati, OH, ³Christ Hospital, Cincinnati, OH, ⁴UIC, Chicago, IL, ⁵Tampa Gen, Tampa, FL, ⁶U Wisconsin, Madison, WI, ⁷Centura Transplant, Denver, CO
*Purpose: Two belatacept(BELA) fixed mg/kg dosing regimens, less intense(LI) and more intense(MI) were compared. The LI regimen was approved due to the higher risk profile…
2021 American Transplant Congress
VO_2peak Differentiates Survival Post Kidney Transplant
H. Chakkera¹, B. Kaplan², P. Budhiraja¹, R. Butterfield¹
¹Mayo Clinic Hospital, Phoenix, AZ, ²Baylor Scott and White Health, Temple, TX
*Purpose: The OPTN/UNOS utilizes the calculated estimated posttransplant survival (EPTS) score as the measure of post-kidney transplant survival to guide allocation of deceased donor kidney…
2021 American Transplant Congress
Long-Term Outcomes in Older Kidney Transplant Recipients from Older Donors
E. Cuadrado-Payán, E. Montagud-Marrahi, J. Casals-Urquiza, J. del Risco-Zevallos, D. Cucchiari, P. Ventura-Aguiar, I. Revuelta, G. Piñeiro, N. Esforzado, F. Cofan, J. Ugalde, J. Campistol, F. Oppenheimer, J. Torregrosa, F. Diekmann
Nephrology and Kidney Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain
*Purpose: The age of patients referred for kidney transplantation has increased progressively. However, the precise influence of age on hard outcomes after transplantation is controversial*Methods:…
2021 American Transplant Congress
Optimizing Usage of High KDPI Kidneys
Y. Ng¹, C. Kling², L. Sibulesky², J. Perkins²
¹Medicine/Nephrology, University of Washington, Seattle, WA, ²Surgery/Transplant, University of Washington, Seattle, WA
*Purpose: Among recipients of high kidney donor profile index (KDPI) kidneys, it is unclear if certain recipients fair better than others. Using data from the…
2021 American Transplant Congress
Health-related Quality of Life (HRQoL) in Patients on Dialysis and Kidney Transplant Recipients – Experience with the PROMIS Global-10 Survey
G. Chawla, W. Hajjar, M. Dastgheib, N. Yanga, G. Ahmadzadeh, N. El-Dassouki, A. Shahreza, N. Al Kaabi, N. Edwards, I. Mucsi
University Health Network, Division of Nephrology and Multi-Organ Transplant Program, Toronto, ON, Canada
*Purpose: The PROMIS (Patient-Reported Outcomes Measurement Information System) Global-10 survey has been used to assess HRQoL in population surveys and studies including patients with chronic…
2021 American Transplant Congress
Information-Seeking Behavior During Covid-19: Opportunities for Communication and Care Transition Improvements
S. H. Advani¹, S. M. Advani², Y. A. Iraheta³, A. Murillo⁴, H. A. Gritsch³, A. D. Waterman³
¹Terasaki Institute, Bethesda, MD, ²National Human Genome Research Institute, Bethesda, MD, ³UCLA, Los Angeles, CA, ⁴Terasaki Institute, Los Angeles, CA
*Purpose: To learn more about how at-risk dialysis and transplant patients sought health information during COVID-19 and what was most helpful, we conducted a mixed-methods…
2021 American Transplant Congress
The Seattle Heart Failure Model is a Predictor of Mortality After Kidney Transplant in Patients with End Stage Renal Disease and Heart Impairment
A. Perez-Gutierrez¹, P. J. Bachul², D. N. Danz³, B. Juengel², M. Josephson², J. Fung², P. Witkowski², B. Chung⁴, Y. Becker²
¹Surgery, University of Chicago, Chicago, IL, IL, ²Surgery, University of Chicago, Chicago, IL, ³Economics, University of Pittsburgh, Pittsburgh, IL, ⁴Cardiology, University of Chicago, Chicago, IL
*Purpose: Cardiovascular disease is the main cause of mortality after kidney transplantation. Many patients with ESRD have heart failure that is attributed to fluid overload.…
2021 American Transplant Congress
Safety and Tolerability of Tacrolimus Extended-Release (astagraf Xl) in Hla Sensitized Kidney Transplant Recipients: A Single Center Experience
A. A. Vo, N. Ammerman, E. Huang, A. Peng, R. Najjar, S. Sethi, K. Lim, M. Gillespie, S. C. Jordan
Cedars Sinai Medical Ctr, Los Angeles, CA
*Purpose: Pill burden is a limitation in kidney transplant. Tacrolimus extended-release (Astagraf XL) is a once daily formulation approved for kidney transplantation. Increased compliance could…
2021 American Transplant Congress
Calcineurin Inhibitor Dose and Selection, Not Antiproliferatives or Steroids, Influence Development of DSA One Year Post-kidney Transplant
M. Henderson¹, G. Morris², L. Awdishu¹, K. Fabbri¹, M. Shah³, A. Khan³, J. Kerr¹
¹Pharmacy, University of California San Diego Health, San Diego, CA, ²Pathology, University of California San Diego Health, San Diego, CA, ³Nephrology, University of California San Diego Health, San Diego, CA
*Purpose: Allograft rejection is a serious complication in kidney transplantation (KT). Despite advances in immunosuppression, acute rejection remains a concern in the first year of…